Course of pregnancy and childbirth in comorbid patients with gestational diabetes mellitus

Abstract

AIM: This study aimed to assess the course of pregnancy and childbirth in comorbid patients with gestational diabetes mellitus (GDM).

MATERIALS AND METHODS: This retrospective analysis enrolled 168 individual cards of pregnant women and women in labor with GDM between 2018 and 2020.

RESULTS: Analysis of the comorbid background of pregnant women revealed the presence of overweight and obesity in 48.2% of patients. Thus, these conditions were attributed as determinants in the development of GDM. In 58.7% patients, delivery was performed by cesarean section; however, in 11.3% of pregnant women, surgical delivery was performed for the first time; the main indication for it was a large fetus.

CONCLUSION: Comorbid background in pregnant women contributes to GDM development, which causes a high percentage of obstetric complications and diabetic fetopathy. The risk strategy for this pathology involves predicting complications using continuous outpatient observation, timely treatment, and hospitalization in accordance with the degree of risk.

Keywords

pregnant women / gestational diabetes mellitus / comorbidity

References

[1] Savel’eva GM, Sukhikh GT, Serov VN, Radzinskii VE, eds. Midwifery. National leadership. 2nd edition. Moscow: GEHOTAR-Media; 2019. 1080 p. (In Russ).

[2] Акушерство. Национальное руководство / под ред. Г.М. Савельевой, Г.Т. Сухих, В.Н. Серова, В.Е. Радзинского. 2-е изд. Москва: ГЭОТАР-Медиа, 2019. 1080 с.

[3] Russian Association of Endocrinologists, Russian Society of Obstetricians and Gynecologists. Gestational diabetes mellitus. Diagnosis, treatment, obstetric tactics, postpartum observation. Clinical recommendations. 2020. 53 p. (In Russ).

[4] Российская ассоциация эндокринологов, Российское общество акушеров-гинекологов. Гестационный сахарный диабет. Диагностика, лечение, акушерская тактика, послеродовое наблюдение. Клинические рекомендации. 2020. 53 с.

[5] Dedov II, Krasnopol’skii VI, Sukhikh GT, on behalf of research group. Russian National Consensus Statement on gestational diabetes: diagnosis, treatment and postnatal care. Sakharnyi diabet. 2012;(4):4–10. (In Russ).

[6] Дедов И.И., Краснопольский В.И., Сухих Г.Т., от имени рабочей группы. Российский национальный консенсус «Гестационный сахарный диабет: диагностика, лечение, послеродовое наблюдение» // Сахарный диабет. 2012. № 4. С. 4–10.

[7] International Diabetes Federation. Diabetes. Atlas. 9th edition. Brussels, Belgium: International Diabetes Federation; 2019.

[8] International Diabetes Federation. Diabetes. Atlas. 9th edition. Brussels, Belgium : International Diabetes Federation, 2019.

[9] Gvozdev AA, Korol’kova AA. Development factors and prediction of gestational diabetes mellitus. Bulletin of Russian State Medical University. 2014;(2):8. (In Russ).

[10] Гвоздев А.А., Королькова А.А. Факторы развития и прогнозирования гестационного сахарного диабета // Вестник Российского государственного медицинского университета. 2014. № 2. С. 8.

[11] Scholtens DM, Kuang A, Lowe LP, et al.; HAPO Follow-Up Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcome follow-up study (HAPO FUS): maternal gestational diabetes mellitus and childhood glucose metabolism. Diabetes Care. 2019;42(3):381–392. doi: 10.2337/dc18-2021

[12] Scholtens D.M., Kuang A., Lowe L.P., et al.; HAPO Follow-Up Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcome follow-up study (HAPO FUS): maternal gestational diabetes mellitus and childhood glucose metabolism // Diabetes Care. 2019. Vol. 42, N 3. P. 381–392. doi: 10.2337/dc18-2021

[13] HAPO Study Cooperative Research Group; Metzger BE, Lowe LP, Dyer AR, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358(19):1991–2002. doi: 10.1056/NEJMoa0707943

[14] HAPO Study Cooperative Research Group; Metzger B.E., Lowe L.P., Dyer A.R., et al. Hyperglycemia and adverse pregnancy outcomes // N Engl J Med. 2008. Vol. 358, N 19. P. 1991–2002. doi: 10.1056/NEJMoa0707943

[15] Sebko TV, Dobrokhotova YuEh, Ivanova TA, et al. Genetic markers of insulin resistance in gestational diabetes mellitus. Diabetes Mellitus. 2009;(4):38–41. (In Russ).

[16] Себко Т.В., Доброхотова Ю.Э., Иванова Т.А., и др. Генетические маркеры инсулинорезистентности при гестационном сахарном диабете // Сахарный диабет. 2009. № 4. С. 38–41.

[17] Demidova TYu, Ushanova FO. Pathophysiological aspects of the development of gestational diabetes mellitus. Russian Medical Journal. Russian Medical Inquiry. 2019;3(10-2):86–91. (In Russ).

[18] Демидова Т.Ю., Ушанова Ф.О. Патофизиологические аспекты развития гестационного сахарного диабета // Русский медицинский журнал. Медицинское обозрение. 2019. Т. 3, № 10-2. С. 86–91.

[19] Zhang C, Bao W, Rong Y, et al. Genetic variants and the risk of gestational diabetes mellitus: a systematic review. Hum Reprod Update. 2013;19(4):376–390. doi: 10.1093/humupd/dmt013

[20] Zhang C., Bao W., Rong Y., et al. Genetic variants and the risk of gestational diabetes mellitus: a systematic review // Hum Reprod Update. 2013. Vol. 19, N 4. Р. 376–390. doi: 10.1093/humupd/dmt013

[21] Lysenko SN, Chechneva MA, Petrukhin VA, Burumkulova FF. Ultrasound diagnosis of diabetic fetopathy. Doktor.Ru. 2019;(7):19–23. doi: 10.31550/1727-2378-2019-162-7-19-23

[22] Лысенко С.Н., Чечнева М.А., Петрухин В.А., Бурумкулова Ф.Ф. Ультразвуковая диагностика диабетической фетопатии // Доктор.Ру. 2019. № 7 (162). С. 19–23. doi: 10.31550/1727-2378-2019-162-7-19-23

[23] Chen D, Xia G, Xu P, Dong M. Peripartum serum leptin and soluble leptin receptor levels in women with gestational diabetes. Acta Obstet Gynecol Scand. 2010;(89):1595–1599. doi: 10.3109/00016349.2010.514040

[24] Chen D., Xia G., Xu P., Dong M. Peripartum serum leptin and soluble leptin receptor levels in women with gestational diabetes // Acta Obstet Gynecol Scand. 2010. № 89. P. 1595–1599. doi: 10.3109/00016349.2010.514040

RIGHTS & PERMISSIONS

Eco-Vector